Pfizer and other pharmaceutical firms have called on the Alabama Supreme Court to reconsider its ruling to hold brand-name drug companies responsible for physical injuries caused by a generic version of acid reflux drug Reglan. Critics said that the ruling may hamper innovation and decrease the number of newly developed drugs in the country.

Full Story:
The Epoch Times

Related Summaries